Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ARADIGM CORP. ARDM -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (46)	12/10/1999 9:57:00 AM
From: Arthur Radley	Read Replies (1) \| Respond to of 255

Rick, I don't see VIRS on his list. Sure would have been nice to have gotten in on ARDm yesterday. I had a bid in this morning but didn't get a fill...don't plan to chase it. What do you think about TTP?(:>)

To: scaram(o)uche who wrote (46)	12/10/1999 12:16:00 PM
From: JMarcus	Read Replies (1) \| Respond to of 255

At the Informed Investors Forum on Nov. 20th, Kellie Seringer, a principal and senior research analyst at Evolution Capital, couldn't seem to say enough good things about ARDM. She loves all the electronic control and monitoring it allows: precise dosage (the Inhale product comes in fixed units of different quantities--you can mix and match to get the precise dosage you need, but it is a hassle), lock-out protection (once Aradigm's product for breakthrough cancer pain is approved, you can kiss Anesta's product goodbye, she says), and digital recordkeeping of actual dosing. She would get starry-eyed when she talked about the company. Marc